Abstract
A genetic polymorphism of apolipoprotein E was first described in 1977 and it was shown at that time that one phenotype in this genetic system is associated with primary dysbetalipoproteinemiaJ It is now well established that genetic apo E polymorphism is under the control of 3 common alleles (∑2, ∑3, ∑4) at the apo E structural gene locus, that specify for isoforms E2, E3, and E4 and have frequencies of 0.077 (∑2), 0.773 (∑3) and 0.150 (∑4) in the German population.2,3 Apo E2 and apo E4 differ from the parent apo E3 isoform by single cysteine for arginine interchanges at one of two positions in the primary structure: apo E2 (Arg158 → Cys) and apo E4 (Cys-112 → Arg).4,5 Examination of a DNA sequence that included the known apo E polymorphic sites showed that the mutant apo E phenotypes can be explained on the basis of a single base substitution in the first position of each of the respective codons.6
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G. Utermann, M. Hees, and A. Steinmetz, Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man, Nature 269: 604 – 607 (1977).
V. I. Zannis, P. W. Just, and J. L. Breslow, Human apolipoprotein E isoprotein subclasses are genetically determined, Am. J. Hum. Genet. 33: 11 – 24 (1981).
G. Utermann, A. Steinmetz, and W. Weber, Genetic control of human apolipoprotein E polymorphism: Comparison of one- and two-dimensional techniques of isoprotein analysis, Hum. Genet. 60: 344 – 351 (1982).
K. H. Weisgraber, S. C. Rail, Jr., and R. W. Mahley, Human E apolipoprotein heterogeneity: cysteine-arginine inter-changes in the aminoacid sequence of the apo E isoforms, J. Biol. Chem. 256: 9077 – 9081 (1981).
S. C. Rail, Jr., K. H. Weisgraber, and R. W. Mahley, Human apolipoprotein E: The complete amino acid sequence, J. Biol. Chem. 257: 4171 – 4178 (1982).
J. L. Breslow, J. McPherson, A. L. Nussbaum, H. W. Williams, R. Lofquist-Kahl, S. K. Karathanasis, and V. I. Zannis, Identification and DNA sequence of a human apolipoprotein E cDNA clone, J. Biol. Chem. 257: 14639 – 14641 (1982).
S. C. Rail, Jr., K. H. Weisgraber, T. L. Innerarity, and R. W. Mahley, Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects, Proc. Natl. Acad. Sci., U.S.A., 79: 4696 - 4700 (1982).
S. C. Rail, Jr., K. H. Weisgraber, T. L. Innerarity, and R. Mahley, Structure and function of apolipoprotein E: Exis-tence of multiple E2 alleles in type III hyperlipoproteinemia, in: “Proceedings from the International Symposium on Latent Dysbetalipoproteinemias and Atherosclerosis,” J. L. de Gennes and R. Paoletti, ed., Raven Press, New York, In Press (1983).
L. M. Havekes, J. A. Gevers Leuven, E. van Corven, E. de Wit, and J. J. Emeis, Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinemia patient, Eur. J. Clin. Invest., In Press (1983).
W. J. Schneider, P. T. Kovanen, M. S. Brown, J. L. Goldstein, G. Utermannn, W. Weber, R. J. Havel, L. Kotite, J. P. Kane, T. L. Innerarity, and R. W. Mahley, Familial dysbetalipoproteinemia: Abnormal binding of mutant apolipoprotein E to LDL receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows, J. Clin. Invest. 68: 1075 – 1085 (1981).
K. H. Weisgraber, T. L. Innerarity, and R. W. Mahley, Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site, J. Biol. Chem. 257: 2518 – 2521 (1982).
R. J. Havel, Y. S. Chao, E. E. Windier, L. Kotite, and S. Guo, Isoprotein specifity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia, Proc. Natl. Acad. Sci. USA 77: 4349 – 4353 (1980).
R. E. Gregg, L. A. Zech, E. J. Schaefer, and H. B. Brewer, Jr., Type III hyperlipoproteinemia: Defective metabolism of an abnormal apolipoprotein E, Science 211: 584 – 586 (1981).
G. Utermann, K. H. Vogelberg, A. Steinmetz, W. Schoenborn, N. Pruin, M. Jaeschke, M. Hees, and H. Canzler, Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III, Clin. Genet. 15: 37 – 62 (1977).
G. Utermann, N. Pruin, and A. Steinmetz, Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man, Clin. Genet. 15: 63 – 72 (1979).
W. R. Hazzard, G. R. Warnick, G. Utermann, and J. J. Albers, Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: Relationship to dysbetalipoproteinemia and hyperlipidemia, Metabolism 30: 79 – 88 (1981).
S. C. Rall, K. H. Weisgraber, T. L. Innerarity, R. W. Mahley, and G. Assmann, Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, hypercholesterolemia dysbetalipoproteinemia, J. Clin. Invest. 71: 1023 – 1031 (1983).
M. R. Wardell, P. A. Suckling, and E. D. Janus, Genetic variation in human apolipoprotein E., J. Lipid Res. 23: 1174 – 1182 (1982).
G. Utermann, K. H. Weisgraber, W. Weber, and R. W. Mahley, Genetic polymorphism of apoliprotein E: Variable forms of apolipoprotein E2 distinguished on sodium dodecyl sulfate- polyacrylamide electrophoresis, manuscript submitted (1983).
G. Utermann, Apolipoprotein E: Role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III, La Ricerca in Clinica e in Laboratorio 12: 23 – 33 (1982).
G. Utermann, Coronary heart disease, in: “Principles and Practice of Medical Genetics,”A. E. H. Emery and D. L. Rimoin, eds., Churchill Livingstone Publ., Edinburgh, N.Y. (1983).
G. Utermann, M. Jaeschke, and J. Menzel, Familial hyperlipoproteinemia type III. Deficiency of a specific apolipoprotein (Apo E-III) in the very low-density lipoproteins, FEBS- Letters 56: 352 – 355 (1975).
G. Utermann, H. Canzler, M. Hees, M. Jaeschke, G. Muehlfellner, W. Schoenborn, K. H. Vogelberg, Studies on the metabolic defect in Broad-disease (hyperlipoproteinemia type III), Clin. Genet. 12: 139 – 154 (1977).
A. Pagnan, R. J. Havel, P. Kane, and L. Kotite, Characterization of human very low-density lipoproteins containing two electro- phoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia, J. Lipid Res. 18: 613 – 622 (1977).
J. L. Breslow, V. I. Zannis, T. R. San Giacomo, J. L. H. C. Thirs, T. Tracy, and C. J. Glueck, Studies of familial type III hyperlipoproteinemia using as a genetic marker the apo E phenotype E-2/2, J. Lipid Res. 23: 1224 – 1235 (1982).
G. R. Warnick, C. Mayfield, J. J. Albers, and W. R. Hazzard, Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type III, Clin. Chem. 25: 279 – 284 (1979).
W. S. Weidman, B. Suarez, J. M. Falko, J. L. Witzum, J. Kolar, M. Roben, and G. Schonfeld, Type III hyperlipoproteinemia: Development of a VLDL apo E gel isoelectric focusing technique and application in family studies, J. Lab. Clin. Med. 13: 549 – 569 (1979).
G. Ghiselli, R. E. Gregg, L. A. Zech, E. J. Schaefer, and H. B. J. Brewer, Phenotype study of apolipoprotein E isoforms in hyperlipoproteinemic patients, Lancet 1: 405 – 407 (1982).
P. M. Stuyt, A. F. H. Stalenhoef, P. N. M. Demacker, and A. van’t Laar, Hyperlipoproteinemia type V and apolipoprotein E4, Lancet, p. 934 (1982).
G. Utermann, H. Kaffarnik, and A. Steinmetz, Apolipoprotein E phenotypes in hyperlipidemia, Hum. Genet., In Press (1983).
G. Utermann, A. Hardewig, and F. Zimmer, Apo E phenotypes in patients with myocardial infarction, Hum. Genet., In Press (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Utermann, G. (1985). Apolipoprotein E Mutants, Hyperlipidemia and Arteriosclerosis. In: Kritchevsky, D., Holmes, W.L., Paoletti, R. (eds) Drugs Affecting Lipid Metabolism VIII. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2459-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2459-1_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9493-1
Online ISBN: 978-1-4613-2459-1
eBook Packages: Springer Book Archive